Reveal. Better Life.
Brand Story

General Biologicals Corporation (GBC) — Advancing Diagnostics, Empowering Better Health
Founded in 1984, General Biologicals Corporation (GBC) is a pioneer in Taiwan’s in-vitro diagnostics (IVD) industry, originating from the National Hepatitis Prevention Program initiated by the Executive Yuan. For over 40 years, GBC has been committed to developing accurate, innovative, and accessible diagnostic solutions that improve global healthcare outcomes.
As a GMP-certified and ISO 13485-compliant manufacturer, GBC specializes in the research, development, production, and worldwide distribution of IVD products and technologies. Our solutions are trusted in 40+ countries, supporting hospitals, clinical laboratories, blood banks, and healthcare professionals with reliable diagnostic tools.
Our Core Expertise
• Infectious & Respiratory Diseases
• Blood-Borne Viruses
• Fertility & Sexual Health
• Oncology & Tumor Markers
• Human Genetics
• Emerging Infectious Diseases
Leveraging advanced protein and nucleic acid diagnostic platforms, GBC has built a fully integrated value chain — from R&D and manufacturing to clinical applications and laboratory services — driving innovation in precision diagnostics.
Looking ahead, GBC is expanding beyond traditional IVD into high-value, integrated healthcare solutions through its subsidiaries:
• CurieMed & Danner Lab — Digital medical diagnostics and clinical laboratory services
• GBP — Antimicrobial peptide (AMP) drug development and consumer healthcare applications
With global reach, cutting-edge technologies, and a mission to make world-class diagnostics affordable and accessible to all, GBC continues to transform healthcare and empower better lives.
Vision
To lead the world in integrated diagnostics and healthcare innovation, setting the benchmark for quality, accessibility, and trust.
Mission
To create and deliver state-of-the-art diagnostic and healthcare technologies that transform clinical decisions and improve lives worldwide.
Values That Drive Our Innovation
Integrity
We embrace honesty, transparency, and accountability to build lasting trust and shared growth with our employees, customers, and partners.
Insight
We anticipate healthcare trends and proactively innovate to empower our customers to achieve their goals effectively.
Integration
We connect people, knowledge, and technologies to create seamless solutions across diagnostics, pharma, and consumer health.
Innovation
Innovation is at our core. We continuously enhance our technologies and solutions to advance diagnostics and improve global healthcare.
Security
From safeguarding population health through diagnostics to ensuring our employees’ well-being, we maintain rigorous research, manufacturing, and workplace standards.
Solution
Beyond manufacturing, we deliver knowledge, expertise, and personalized solutions that address the unique needs of every customer and industry.
Adaptability
In a rapidly evolving healthcare landscape, we remain agile—adapting swiftly to changing technologies, regulations, and customer expectations.
Swipe left to view all
Business Areas

Join GBC. Shape the Future of Healthcare.
Be part of a global team driving diagnostics, therapeutics, and innovation that improve lives worldwide
Leadership
Director of General Biologicals Corp.
GB GENES CORP. Chairman
Director of GB GENES CORP.
Representative of Juristic Person of GB GENES CORP.
Representative of Juristic Person of Viarich Biotechnology Co., Ltd
B.A.in New York University, Master of Business.
10+ Extensive experiences and roles in sales marketing.
Supervising clinical laboratory and a clinic.
1998-Head of Laboratory Department, Chenxin Hospital
2002-Head of Department of Nuclear Medicine Immunology Laboratory, Hsinchu Hospital
2005-Director of Quality Control Department of CurieMed Corp
2010-Director of CurieMed Corp Medical Laboratory
2013-Director of Quality Control Department of General Biologicals Corp.
2014-General Biologicals Corp. Senior Project Manager
2019-General Biologicals Corp. Director
The Open University of Hong Kong Postgraduate Certificate in Business Administration
1996-Thermo Fisher Scientific commercial leader Northeast Asia
2012-DYNEX TECHNOLOGIES, Inc. Asia Pacific Sales Director
Board Members
General Biologicals Corp. Chairman & CEO
Danner Lab Inc Chairman & CEO
Pacgen Life Science Chairman & CEO
CurieMed Corporation Chairman & CEO
GB GENES CORP. Board director
Taiwan Genomic Industry Alliance Inc. Board Director
Ace Medical Technology Co., Ltd Board Director
CHLITINA Holding Limited. Chairman
Representative of Juristic Person of General Biologicals Corp.
Director of General Biologicals Corp.
GB GENES CORP. Chairman
Director of GB GENES CORP.
Representative of Juristic Person of GB GENES CORP.
Representative of Juristic Person of Viarich Biotechnology Co., Ltd
Coming Soon
Coming Soon
Board Members
Coming Soon
Academia Sinica Visiting Chair Professor
NCKU Adjunct Professor
Moderator of the Ministry of Science and Technolohy
NTOU National Taiwan Ocean University Chair Professor
Independent Director, PRIT Biotech Co. Ltd.
Independent Director, General Biologicals Corp.
President, Glonova Co.
Consultant, T-TOP Clinical Research Co.
Director, Yolk Partners Co.
Independent Director, General Biologicals Corp.
Coming Soon
History
The year it all got started.

Founded and funded by Taiwan Government, GBC was created as part of Taiwan’s national ‘Hepatitis Prevention and Vaccine Program’. Dr. Zong Mei Lin, the founder of GBC, used ‘Direct Sandwich’ antibody technology in the manufacture of HBV diagnostic kits.
The first products are launched.

Our RIA (Radioimmunoassay) products are released, making us the only RIA company in Taiwan, with Hepatitis tests being the first product line to be launched.
We introduce the first immunoassay (ELISA) products.

GBC is proud to announce new hepatitis products: HBsAg and anti-HCV. These two products have gone on to remain the top sellers within the industry even after 30 years.
GBC enters the laboratory services market.

GBC acquires its first company proving solutions for hospitals, CurieMed, to enter the service industry. CurieMed provides quality tests samples collected from hospitals, clinics, and other labs as well as BOT solutions.
Taiwan GMP Certified.
Diversification

GBC expands its business portfolio by investing in StemCyte Inc., a global leader in cord blood therapeutics that offers public and private cord blood banking.
Knowing someone has hepatitis B is not enough — doctors need to know the viral load in order to correctly treat and monitor the condition. To this end, we launch our first GB HBV RealQuant PCR Kit.
With Liver Fibrosis a critical part of liver disease that clinical doctors needed to identify, we started working with ITRI (Industrial Technology Research Institute of Taiwan). As a result, BioFibroScore® is born.
Expansion in the south with the Kaohsiung Science Park.
GBC becomes certified by the Taiwan Train Quality System (TTQS).
Our 30th Anniversary.
For more than 30 years, GBC has focused on creating high-performance diagnostic technologies that are available to all.
New drug development

GBC develops its first drug, P113, a therapeutic peptide drug for the topical treatment of Oral Candidiasis. P113 finishes its promising Phase IIb FDA clinical trial, proving effective for gingivitis, candida albicans, vaginal Candidiasis, Cystic fibrosis, and anti-plague for dogs’ teeth.
Acquisition to strengthen service business in USA

GBC acquires Danner Laboratory located in San Diego, CA USA. Danner Laboratory offers cytology and molecular tests in addition to all hepatitis, tumor markers, fertility, infectious disease, and thyroid tests manufactured by GBC.
Heading toward personalized healthcare
With diagnostics and drugs are dependent upon each other more than ever, new non-invasive technologies are being developed that diagnosis diseases that couldn’t be detected before. GBC’s is developing these groundbreaking products through partnerships in Taiwan, China, the USA, and Canada.
P113+

P113+ is certified by CTFA as an INCI (International Nomenclature Cosmetic Ingredient).
GBC enters the personal care and cosmetics market

GBC establishes its own consumable brand name ‘oh care’ to launch oral care, feminine products, pets, and medical devices all using the P113 peptide ingredient.
Expanded our sales marketing office in Dongguan, China
We expand our sales marketing office in Dongguan, China, concentrating on our IVD and personal care products.
CellBio Technology is launched, a Liquid Biopsy application that helps cancer cell early detection, drug selection, and disease monitoring.

Clinical Lab established

Our Clinical Lab is setup in Vancouver, BC, Canada, to provide clinical services such as COVID-19.
Awards
| Title | Awarded by | Year | |
|---|---|---|---|
|
2025 US Edison Awards
|
Edison Awards | 2025 | |
|
2025 Taiwan Excellence Award
|
International Trade Administration | 2025 | |
|
2024 SNQ Symbol of National Quality Certification
|
Institute for Biotechnology and Medicine Industry (IBMI) | 2024 | |
|
2023 National Innovation Award
CellBio™ CTC System |
National Biotechnology and Medical Industry Promotion Association | 2023 | |
|
National Pharmaceutical Technology & Research Development Awards
GBC CellBio™ Technology Platform received the Bronze Award at the National Pharmaceutical Technology & Research Development Awards. |
TFDA / Ministry of Economic Affairs | 2023 | |
|
2022 Asia Pacific Enterprise Awards
https://apea.asia/hall-of-fame-tw-2022/ |
Enterprise Asia | 2022 | |
|
2022 HR Asia Best Companies to Work for in Asia
2022 HR Asia Best Companies to Work for in Asia |
HR Asia | 2022 | |
|
The 19th National Innovation Award – Enterprise Innovation Award
The 19th National Innovation Award – Enterprise Innovation Award “Blood Circulating Tumor Cell Detection System (CellBioTM)” https://innoaward.taiwan-healthcare.org/ |
National Biotechnology and Medical Industry Promotion Association | 2022 | |
|
2021 Top 100 MVP Managers – Product Innovation Award
Product Innovation Award |
Manager magazine | 2021 | |
|
2020 Pharmaceutical Technology & Research Development Award
GB SARS-CoV-2 Real-Time RT-PCR |
TFDA / Ministry of Economic Affairs | 2020 | |
|
2020 SNQ National Biotech Industrial Award
BioFibroScore® Non-invasive liver fibrosis detection platform was awarded Bronze Award in SNQ National Biotechnology and Medical Quality by Department of Economics Development Taiwan. |
Department of Economics Development Taiwan | 2020 | |
|
2019 SNQ National Biotech Industrial Award
BioFibroScore® Non-invasive liver fibrosis detection platform was awarded Bronze Award in SNQ National Biotechnology and Medical Quality by Department of Economics Development Taiwan. |
Department of Economics Development Taiwan | 2019 | |
|
2018 SNQ National Quality Award
BioFibroScore® was awarded 2015 SNQ National Quality Award |
Institute for Biotechnology and Medicine Industry Taiwan | 2018 | |
|
The 15th Annual Taiwan Golden Root Awards
|
Taiwan Industrial Technology Association (TITA) | 2018 | |
|
2017 SNQ National Biotech Industrial Award
BioFibroScore® Non-invasive liver fibrosis detection platform was awarded Bronze Award in SNQ National Biotechnology and Medical Quality by Department of Economics Development Taiwan. |
Department of Economics Development Taiwan | 2017 | |
|
2016 SNQ National Biotech Industrial Award
BioFibroScore® Non-invasive liver fibrosis detection platform was awarded Bronze Award in SNQ National Biotechnology and Medical Quality by Department of Economics Development Taiwan. |
Department of Economics Development Taiwan | 2016 | |
|
2015 Asia Pacific Entrepreneuship Awards
Chairman T.C. Lin was awarded one of the 7 Most Promising Entrepreneurship Award. |
Asia Pacific Entrepreneurship Awards (APEA) | 2015 | |
|
2015 Troponin-I POCT Excellence Award
GBC’s newest POCT (Point of Care Testing) system was awarded an Excellence Award by Ministry of Science and Technology Taiwan |
Ministry of Science and Technology Taiwan | 2015 | |
|
2014 Taipei Biotechnology Award
BioFibroScore® – a non-invasive liver fibrosis platform was awarded Gold Award in Taipei Biotechnology Award by Department of Economics Development Taiwan |
Department of Economics Development Taiwan | 2014 | |
|
The 2nd Taiwan Mittelstand Award
GBC was awarded for the 2nd Taiwan Mittelstand and Counseling Targets from Industrial Development Bureau,Ministry of Economic Affairs. |
Industrial Development Bureau Ministry of Economic Affairs | 2014 | |
|
The 10th National Innovation Award
GBC was awarded by The Institute for Biotechnology and Medicine Industry (IBMI) “The 10th National Innovation Award”. |
The Institute for Biotechnology and Medicine Industry (IBMI) | 2013 | |
|
2013 Honor Award of Golden Torch Award Selection
GBC was awarded by Honor Award of Golden Torch Award Selection. The award celebration was hosted by Chinese Outstanding Enterprise Manager Association |
Chinese Outstanding Enterprise Manager Association | 2013 | |
|
2013 Taiwan BIO Award – Innovation of the Year
GBC was awarded by Bio Taiwan Industry Organization “2013 Taiwan BIO Award – Innovation of the Year”. |
Bio Taiwan Industry Organization | 2013 | |
|
2012 Industrial Innovation Recognition Award
The award was established by Economic Department Technology Department in Taiwan to encourage new innovation from small to large companies. GBC was awarded as one of “Best Innovations in Technology in 2012” categories. |
Ministry of Economic Affairs Taiwan | 2012 | |
|
The 9th Annual Taiwan Golden Root Awards
The Annual Taiwan Golden Root Awards are giving out to the most prominent with the highest potential in Taiwan by TITA (Taiwan Industrial Technology Association). Only a limited of companies were selected each year. GBC was awarded in 2011. |
Taiwan Industrial Technology Association (TITA) | 2011 | |
|
2010 D&B and Standard Chartered Award
GBC was awarded as one of top 100 the most respectful high tech company in Taiwan by Standard Chartered. |
Standard Chartered | 2010 | |
|
The 8th Annual the Most Innovative Product Design Award
GBC was awarded by Taiwan Government (small-medium business division) one of the most innovative companies in year 2001. |
Ministry of Economic Affairs Taiwan | 2001 | |
|
The National Biotech Industrial Award
The award was considered to be equivalent to “Oscar Award” and was the most prestige award in Life Science / Biotech industry in Taiwan. We at GBC were selected as one of top 4 companies in year 2000. |
he Institute for Biotechnology and Medicine Industry (IBMI) | 2000 |
Edison Awards
2025
International Trade Administration
2025
Institute for Biotechnology and Medicine Industry (IBMI)
2024
CellBio™ CTC System
National Biotechnology and Medical Industry Promotion Association
2023
GBC CellBio™ Technology Platform received the Bronze Award at the National Pharmaceutical Technology & Research Development Awards.
TFDA / Ministry of Economic Affairs
2023
https://apea.asia/hall-of-fame-tw-2022/
Enterprise Asia
2022
2022 HR Asia Best Companies to Work for in Asia
HR Asia
2022
The 19th National Innovation Award – Enterprise Innovation Award
“Blood Circulating Tumor Cell Detection System (CellBioTM)”
https://innoaward.taiwan-healthcare.org/
National Biotechnology and Medical Industry Promotion Association
2022
Product Innovation Award
Manager magazine
2021
GB SARS-CoV-2 Real-Time RT-PCR
TFDA / Ministry of Economic Affairs
2020
BioFibroScore® Non-invasive liver fibrosis detection platform was awarded Bronze Award in SNQ National Biotechnology and Medical Quality by Department of Economics Development Taiwan.
Department of Economics Development Taiwan
2020
BioFibroScore® Non-invasive liver fibrosis detection platform was awarded Bronze Award in SNQ National Biotechnology and Medical Quality by Department of Economics Development Taiwan.
Department of Economics Development Taiwan
2019
BioFibroScore® was awarded 2015 SNQ National Quality Award
Institute for Biotechnology and Medicine Industry Taiwan
2018
Taiwan Industrial Technology Association (TITA)
2018
BioFibroScore® Non-invasive liver fibrosis detection platform was awarded Bronze Award in SNQ National Biotechnology and Medical Quality by Department of Economics Development Taiwan.
Department of Economics Development Taiwan
2017
BioFibroScore® Non-invasive liver fibrosis detection platform was awarded Bronze Award in SNQ National Biotechnology and Medical Quality by Department of Economics Development Taiwan.
Department of Economics Development Taiwan
2016
Chairman T.C. Lin was awarded one of the 7 Most Promising Entrepreneurship Award.
Asia Pacific Entrepreneurship Awards (APEA)
2015
GBC’s newest POCT (Point of Care Testing) system was awarded an Excellence Award by Ministry of Science and Technology Taiwan
Ministry of Science and Technology Taiwan
2015
BioFibroScore® – a non-invasive liver fibrosis platform was awarded Gold Award in Taipei Biotechnology Award by Department of Economics Development Taiwan
Department of Economics Development Taiwan
2014
GBC was awarded for the 2nd Taiwan Mittelstand and Counseling Targets from Industrial Development Bureau,Ministry of Economic Affairs.
Industrial Development Bureau Ministry of Economic Affairs
2014
GBC was awarded by The Institute for Biotechnology and Medicine Industry (IBMI) “The 10th National Innovation Award”.
The Institute for Biotechnology and Medicine Industry (IBMI)
2013
GBC was awarded by Honor Award of Golden Torch Award Selection. The award celebration was hosted by Chinese Outstanding Enterprise Manager Association
Chinese Outstanding Enterprise Manager Association
2013
GBC was awarded by Bio Taiwan Industry Organization “2013 Taiwan BIO Award – Innovation of the Year”.
Bio Taiwan Industry Organization
2013
The award was established by Economic Department Technology Department in Taiwan to encourage new innovation from small to large companies. GBC was awarded as one of “Best Innovations in Technology in 2012” categories.
Ministry of Economic Affairs Taiwan
2012
The Annual Taiwan Golden Root Awards are giving out to the most prominent with the highest potential in Taiwan by TITA (Taiwan Industrial Technology Association). Only a limited of companies were selected each year. GBC was awarded in 2011.
Taiwan Industrial Technology Association (TITA)
2011
GBC was awarded as one of top 100 the most respectful high tech company in Taiwan by Standard Chartered.
Standard Chartered
2010
GBC was awarded by Taiwan Government (small-medium business division) one of the most innovative companies in year 2001.
Ministry of Economic Affairs Taiwan
2001
The award was considered to be equivalent to “Oscar Award” and was the most prestige award in Life Science / Biotech industry in Taiwan. We at GBC were selected as one of top 4 companies in year 2000.
he Institute for Biotechnology and Medicine Industry (IBMI)
2000
Locations

— R&D, manufacturing, corporate operations
Zhuchuang Biotech Branch (Zhubei) — Advanced R&D for diagnostics, AMP therapeutics (P113), and digital healthcare

LET’S CONNECT
Discover how GBC’s experts can support your next complex diagnostic project
General Biologicals Corp. Chairman & CEO
Danner Lab Inc Chairman & CEO
Pacgen Life Science Chairman & CEO
CurieMed Corporation Chairman & CEO
GB GENES CORP. Board director
Taiwan Genomic Industry Alliance Inc. Board Director
Ace Medical Technology Co., Ltd Board Director